Tianjin Institute of Materia Medica

Tianjin Institute of Materia Medica (TIMM) is a prominent pharmaceutical research and development organization in China, originally established in 1959 as a state-level institute. It has since evolved into a comprehensive high-tech enterprise that integrates drug discovery, development, and technical services. TIMM specializes in innovative chemical drugs, modernized traditional Chinese medicine (TCM), and advanced drug delivery systems. The institute operates several national-level research platforms, including the National Key Laboratory of Drug Delivery Technology and Pharmacokinetics. As a subsidiary of the Tianjin Pharmaceutical Group, TIMM plays a vital role in bridging academic research with industrial commercialization in the Chinese healthcare sector.